ACOX1 and colorectal carcinoma: Conversely, ACOX1 depletion increased CRC cell viability, which was inhibited by iCRT14, a β-catenin transcriptional activity inhibitor that disrupts the binding of β-catenin to TCF (Fig. 5e; Supplementary Fig. S7g).